ARCHIVES

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

This article is from The Cancer Letter archive.

Vol. 14 No. 43 | November 4, 1988

Download PDF Visit The Full Archive

Related Articles

More Minorities, Women, Fewer MD On Study Sections

September 2, 1988

OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB

October 13, 1989

In Brief: Lane Adams Retires, Gadberry New Executive VP; Lemaistre ACS President, Loeb President Elect

November 15, 1985

Burton’s Clinic Reported Operating In Spite of Closure

December 13, 1985

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

October 14, 2005

RFA Available: Chemoprevention Trials

August 5, 1994